Figure 1.
Figure 1. VWF-dependent platelet function (RCoF) in normal subjects or CLL patients before and during ibrutinib treatment with or without bleeding.

VWF-dependent platelet function (RCoF) in normal subjects or CLL patients before and during ibrutinib treatment with or without bleeding.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal